2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Calcitonin Salmon Injection Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-19E8916
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Calcitonin Salmon Injection Market Outlook 2022
BUY CHAPTERS

Global Calcitonin Salmon Injection Market Research Report 2025

Code: QYRE-Auto-19E8916
Report
June 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Calcitonin Salmon Injection Market Size

The global market for Calcitonin Salmon Injection was valued at US$ 281 million in the year 2024 and is projected to reach a revised size of US$ 492 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Calcitonin Salmon Injection Market

Calcitonin Salmon Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Calcitonin Salmon Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Calcitonin Salmon Injection is used to treat osteoporosis in postmenopausal women. Osteoporosis is a disease that causes bones to weaken and break more easily. Calcitonin salmon injection is also used to treat Paget's disease of bone and to quickly reduce calcium levels in the blood when needed. Calcitonin is a human hormone that is also found in salmon. It works by preventing bone breakdown and increasing bone density (thickness).
Calcitonin Salmon Injection is a well-established therapeutic agent in the management of bone metabolism disorders, particularly osteoporosis and hypercalcemia. The product contains synthetic salmon calcitonin, a 32-amino-acid polypeptide with high affinity for human calcitonin receptors and superior biological activity compared to human calcitonin. Originally developed by Novartis, the product is now owned by Konruns Pharmaceutical, marking its integration into the domestic pharmaceutical innovation chain. It is indicated for the prevention of acute bone loss due to sudden immobilization (e.g., post-fracture), treatment of Paget’s disease of bone, malignancy-induced hypercalcemia, and neurotrophic disorders such as Sudeck’s atrophy. Administered via subcutaneous or intramuscular injection at doses of 50-100 IU per day, it plays a unique role in inhibiting osteoclastic bone resorption. Notably, it is the only calcitonin-based drug approved by China’s NMPA for preventing acute and progressive bone loss, underlining its clinical and regulatory significance. The product enjoys a strong reputation among Chinese clinicians, particularly in postmenopausal osteoporosis treatment and tumor-related bone disease management. Given the aging population and increased awareness of skeletal health, the demand for bone-protective agents like calcitonin salmon is expected to remain stable or grow. Further opportunities may arise with potential reimbursement expansion and enhanced integration into multi-drug osteoporosis treatment regimens.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Calcitonin Salmon Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcitonin Salmon Injection.
The Calcitonin Salmon Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Calcitonin Salmon Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcitonin Salmon Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Calcitonin Salmon Injection Market Report

Report Metric Details
Report Name Calcitonin Salmon Injection Market
Accounted market size in year US$ 281 million
Forecasted market size in 2031 US$ 492 million
CAGR 8.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 400Units/2mL
  • 200Units/1mL
Segment by Application
  • Adult Use
  • Geriatric Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Konruns, Avanc Pharmaceutical, Sl Pharm, Leucadia Pharmaceuticals, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Calcitonin Salmon Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Calcitonin Salmon Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Calcitonin Salmon Injection Market growing?

Ans: The Calcitonin Salmon Injection Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the Calcitonin Salmon Injection Market size in 2031?

Ans: The Calcitonin Salmon Injection Market size in 2031 will be US$ 492 million.

Who are the main players in the Calcitonin Salmon Injection Market report?

Ans: The main players in the Calcitonin Salmon Injection Market are Novartis, Konruns, Avanc Pharmaceutical, Sl Pharm, Leucadia Pharmaceuticals, Sanofi

What are the Application segmentation covered in the Calcitonin Salmon Injection Market report?

Ans: The Applications covered in the Calcitonin Salmon Injection Market report are Adult Use, Geriatric Use

What are the Type segmentation covered in the Calcitonin Salmon Injection Market report?

Ans: The Types covered in the Calcitonin Salmon Injection Market report are 400Units/2mL, 200Units/1mL

1 Calcitonin Salmon Injection Market Overview
1.1 Product Definition
1.2 Calcitonin Salmon Injection by Type
1.2.1 Global Calcitonin Salmon Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 400Units/2mL
1.2.3 200Units/1mL
1.3 Calcitonin Salmon Injection by Application
1.3.1 Global Calcitonin Salmon Injection Market Value by Application (2024 VS 2031)
1.3.2 Adult Use
1.3.3 Geriatric Use
1.4 Global Calcitonin Salmon Injection Market Size Estimates and Forecasts
1.4.1 Global Calcitonin Salmon Injection Revenue 2020-2031
1.4.2 Global Calcitonin Salmon Injection Sales 2020-2031
1.4.3 Global Calcitonin Salmon Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Calcitonin Salmon Injection Market Competition by Manufacturers
2.1 Global Calcitonin Salmon Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Calcitonin Salmon Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Calcitonin Salmon Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Calcitonin Salmon Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Calcitonin Salmon Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Calcitonin Salmon Injection, Product Type & Application
2.7 Global Key Manufacturers of Calcitonin Salmon Injection, Date of Enter into This Industry
2.8 Global Calcitonin Salmon Injection Market Competitive Situation and Trends
2.8.1 Global Calcitonin Salmon Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Calcitonin Salmon Injection Players Market Share by Revenue
2.8.3 Global Calcitonin Salmon Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Calcitonin Salmon Injection Market Scenario by Region
3.1 Global Calcitonin Salmon Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Calcitonin Salmon Injection Sales by Region: 2020-2031
3.2.1 Global Calcitonin Salmon Injection Sales by Region: 2020-2025
3.2.2 Global Calcitonin Salmon Injection Sales by Region: 2026-2031
3.3 Global Calcitonin Salmon Injection Revenue by Region: 2020-2031
3.3.1 Global Calcitonin Salmon Injection Revenue by Region: 2020-2025
3.3.2 Global Calcitonin Salmon Injection Revenue by Region: 2026-2031
3.4 North America Calcitonin Salmon Injection Market Facts & Figures by Country
3.4.1 North America Calcitonin Salmon Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Calcitonin Salmon Injection Sales by Country (2020-2031)
3.4.3 North America Calcitonin Salmon Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Calcitonin Salmon Injection Market Facts & Figures by Country
3.5.1 Europe Calcitonin Salmon Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Calcitonin Salmon Injection Sales by Country (2020-2031)
3.5.3 Europe Calcitonin Salmon Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Calcitonin Salmon Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Calcitonin Salmon Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Calcitonin Salmon Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Calcitonin Salmon Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Calcitonin Salmon Injection Market Facts & Figures by Country
3.7.1 Latin America Calcitonin Salmon Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Calcitonin Salmon Injection Sales by Country (2020-2031)
3.7.3 Latin America Calcitonin Salmon Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Calcitonin Salmon Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Calcitonin Salmon Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Calcitonin Salmon Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Calcitonin Salmon Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Calcitonin Salmon Injection Sales by Type (2020-2031)
4.1.1 Global Calcitonin Salmon Injection Sales by Type (2020-2025)
4.1.2 Global Calcitonin Salmon Injection Sales by Type (2026-2031)
4.1.3 Global Calcitonin Salmon Injection Sales Market Share by Type (2020-2031)
4.2 Global Calcitonin Salmon Injection Revenue by Type (2020-2031)
4.2.1 Global Calcitonin Salmon Injection Revenue by Type (2020-2025)
4.2.2 Global Calcitonin Salmon Injection Revenue by Type (2026-2031)
4.2.3 Global Calcitonin Salmon Injection Revenue Market Share by Type (2020-2031)
4.3 Global Calcitonin Salmon Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Calcitonin Salmon Injection Sales by Application (2020-2031)
5.1.1 Global Calcitonin Salmon Injection Sales by Application (2020-2025)
5.1.2 Global Calcitonin Salmon Injection Sales by Application (2026-2031)
5.1.3 Global Calcitonin Salmon Injection Sales Market Share by Application (2020-2031)
5.2 Global Calcitonin Salmon Injection Revenue by Application (2020-2031)
5.2.1 Global Calcitonin Salmon Injection Revenue by Application (2020-2025)
5.2.2 Global Calcitonin Salmon Injection Revenue by Application (2026-2031)
5.2.3 Global Calcitonin Salmon Injection Revenue Market Share by Application (2020-2031)
5.3 Global Calcitonin Salmon Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Calcitonin Salmon Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Calcitonin Salmon Injection Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Konruns
6.2.1 Konruns Company Information
6.2.2 Konruns Description and Business Overview
6.2.3 Konruns Calcitonin Salmon Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Konruns Calcitonin Salmon Injection Product Portfolio
6.2.5 Konruns Recent Developments/Updates
6.3 Avanc Pharmaceutical
6.3.1 Avanc Pharmaceutical Company Information
6.3.2 Avanc Pharmaceutical Description and Business Overview
6.3.3 Avanc Pharmaceutical Calcitonin Salmon Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Avanc Pharmaceutical Calcitonin Salmon Injection Product Portfolio
6.3.5 Avanc Pharmaceutical Recent Developments/Updates
6.4 Sl Pharm
6.4.1 Sl Pharm Company Information
6.4.2 Sl Pharm Description and Business Overview
6.4.3 Sl Pharm Calcitonin Salmon Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sl Pharm Calcitonin Salmon Injection Product Portfolio
6.4.5 Sl Pharm Recent Developments/Updates
6.5 Leucadia Pharmaceuticals
6.5.1 Leucadia Pharmaceuticals Company Information
6.5.2 Leucadia Pharmaceuticals Description and Business Overview
6.5.3 Leucadia Pharmaceuticals Calcitonin Salmon Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Leucadia Pharmaceuticals Calcitonin Salmon Injection Product Portfolio
6.5.5 Leucadia Pharmaceuticals Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Calcitonin Salmon Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Calcitonin Salmon Injection Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Calcitonin Salmon Injection Industry Chain Analysis
7.2 Calcitonin Salmon Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Calcitonin Salmon Injection Production Mode & Process Analysis
7.4 Calcitonin Salmon Injection Sales and Marketing
7.4.1 Calcitonin Salmon Injection Sales Channels
7.4.2 Calcitonin Salmon Injection Distributors
7.5 Calcitonin Salmon Injection Customer Analysis
8 Calcitonin Salmon Injection Market Dynamics
8.1 Calcitonin Salmon Injection Industry Trends
8.2 Calcitonin Salmon Injection Market Drivers
8.3 Calcitonin Salmon Injection Market Challenges
8.4 Calcitonin Salmon Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Calcitonin Salmon Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Calcitonin Salmon Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Calcitonin Salmon Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Calcitonin Salmon Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Calcitonin Salmon Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Calcitonin Salmon Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Calcitonin Salmon Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Calcitonin Salmon Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Calcitonin Salmon Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Calcitonin Salmon Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Calcitonin Salmon Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Calcitonin Salmon Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Calcitonin Salmon Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calcitonin Salmon Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Calcitonin Salmon Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Calcitonin Salmon Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Calcitonin Salmon Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Calcitonin Salmon Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Calcitonin Salmon Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Calcitonin Salmon Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Calcitonin Salmon Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Calcitonin Salmon Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Calcitonin Salmon Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Calcitonin Salmon Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Calcitonin Salmon Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Calcitonin Salmon Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Calcitonin Salmon Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Calcitonin Salmon Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Calcitonin Salmon Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Calcitonin Salmon Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Calcitonin Salmon Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Calcitonin Salmon Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Calcitonin Salmon Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Calcitonin Salmon Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Calcitonin Salmon Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Calcitonin Salmon Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Calcitonin Salmon Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Calcitonin Salmon Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Calcitonin Salmon Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Calcitonin Salmon Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Calcitonin Salmon Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Calcitonin Salmon Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Calcitonin Salmon Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Calcitonin Salmon Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Calcitonin Salmon Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Calcitonin Salmon Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Calcitonin Salmon Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Calcitonin Salmon Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Calcitonin Salmon Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Calcitonin Salmon Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Calcitonin Salmon Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Calcitonin Salmon Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Calcitonin Salmon Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Calcitonin Salmon Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Calcitonin Salmon Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Calcitonin Salmon Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Calcitonin Salmon Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Calcitonin Salmon Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Calcitonin Salmon Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Calcitonin Salmon Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Calcitonin Salmon Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Calcitonin Salmon Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Calcitonin Salmon Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Calcitonin Salmon Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Calcitonin Salmon Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Calcitonin Salmon Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Calcitonin Salmon Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Calcitonin Salmon Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Calcitonin Salmon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Calcitonin Salmon Injection Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Konruns Company Information
 Table 76. Konruns Description and Business Overview
 Table 77. Konruns Calcitonin Salmon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Konruns Calcitonin Salmon Injection Product
 Table 79. Konruns Recent Developments/Updates
 Table 80. Avanc Pharmaceutical Company Information
 Table 81. Avanc Pharmaceutical Description and Business Overview
 Table 82. Avanc Pharmaceutical Calcitonin Salmon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Avanc Pharmaceutical Calcitonin Salmon Injection Product
 Table 84. Avanc Pharmaceutical Recent Developments/Updates
 Table 85. Sl Pharm Company Information
 Table 86. Sl Pharm Description and Business Overview
 Table 87. Sl Pharm Calcitonin Salmon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sl Pharm Calcitonin Salmon Injection Product
 Table 89. Sl Pharm Recent Developments/Updates
 Table 90. Leucadia Pharmaceuticals Company Information
 Table 91. Leucadia Pharmaceuticals Description and Business Overview
 Table 92. Leucadia Pharmaceuticals Calcitonin Salmon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Leucadia Pharmaceuticals Calcitonin Salmon Injection Product
 Table 94. Leucadia Pharmaceuticals Recent Developments/Updates
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi Calcitonin Salmon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sanofi Calcitonin Salmon Injection Product
 Table 99. Sanofi Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Calcitonin Salmon Injection Distributors List
 Table 103. Calcitonin Salmon Injection Customers List
 Table 104. Calcitonin Salmon Injection Market Trends
 Table 105. Calcitonin Salmon Injection Market Drivers
 Table 106. Calcitonin Salmon Injection Market Challenges
 Table 107. Calcitonin Salmon Injection Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Calcitonin Salmon Injection
 Figure 2. Global Calcitonin Salmon Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Calcitonin Salmon Injection Market Share by Type: 2024 & 2031
 Figure 4. 400Units/2mL Product Picture
 Figure 5. 200Units/1mL Product Picture
 Figure 6. Global Calcitonin Salmon Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Calcitonin Salmon Injection Market Share by Application: 2024 & 2031
 Figure 8. Adult Use
 Figure 9. Geriatric Use
 Figure 10. Global Calcitonin Salmon Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Calcitonin Salmon Injection Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Calcitonin Salmon Injection Sales (2020-2031) & (K Units)
 Figure 13. Global Calcitonin Salmon Injection Average Price (US$/Unit) & (2020-2031)
 Figure 14. Calcitonin Salmon Injection Report Years Considered
 Figure 15. Calcitonin Salmon Injection Sales Share by Manufacturers in 2024
 Figure 16. Global Calcitonin Salmon Injection Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Calcitonin Salmon Injection Players: Market Share by Revenue in Calcitonin Salmon Injection in 2024
 Figure 18. Calcitonin Salmon Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Calcitonin Salmon Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Calcitonin Salmon Injection Sales Market Share by Country (2020-2031)
 Figure 21. North America Calcitonin Salmon Injection Revenue Market Share by Country (2020-2031)
 Figure 22. United States Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Calcitonin Salmon Injection Sales Market Share by Country (2020-2031)
 Figure 25. Europe Calcitonin Salmon Injection Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Calcitonin Salmon Injection Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Calcitonin Salmon Injection Revenue Market Share by Region (2020-2031)
 Figure 33. China Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Calcitonin Salmon Injection Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Calcitonin Salmon Injection Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Calcitonin Salmon Injection Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Calcitonin Salmon Injection Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Calcitonin Salmon Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Calcitonin Salmon Injection by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Calcitonin Salmon Injection by Type (2020-2031)
 Figure 54. Global Calcitonin Salmon Injection Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Calcitonin Salmon Injection by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Calcitonin Salmon Injection by Application (2020-2031)
 Figure 57. Global Calcitonin Salmon Injection Price (US$/Unit) by Application (2020-2031)
 Figure 58. Calcitonin Salmon Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture